FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Implant, Dermal, For Aesthetic Use
PMA: P170002
·
Supplement: S006
·
Decision Jan 30, 2020
Classifications
1
FEI Numbers
29
Registration Numbers
29
Basic Information
- Device Name
- Implant, Dermal, For Aesthetic Use
- Trade Name
- RHA 2, RHA 3, RHA 4
- PMA Number
- P170002
- Supplement Number
- S006
- Device Class
- FDA Class 3
- Product Code
- LMH
- Generic Name
- Implant, dermal, for aesthetic use
- Medical Specialty
- Unknown
- Advisory Committee
- General, Plastic Surgery
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- January 30, 2020
- Date Received
- June 28, 2019
- Supplement Type
- 135 Review Track For 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Approval for a transfer of the lidocaine assay and 2,6-DMA limit test from a contract laboratory to an in-house laboratory.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LMH | Implant, Dermal, For Aesthetic Use | FDA class 3 | Unknown |